Utilizing Recently Approved Biosimilars in Clinical Practice

Experts explore current and future use of biosimilars in dermatology, gastroenterology, and rheumatology.

Related Keywords

Bincy Abraham ,Ryan Haumschild ,Aliceb Gottlieb ,Jamiet Brogan ,Department Of Dermatology ,Academic Division Of Gastroenterology ,Division Of Immunology ,Stanford University School Of Medicine ,Winship Cancer Institute ,Icahn School Of Medicine At Mount Sinai ,Emory Healthcare ,Icahn School ,Mount Sinai ,Academic Division ,Houston Methodist Hospital ,Northwestern Medicine ,Vibeke Strand ,Stanford University School ,Biosimilars ,Adalimumab ,Medicaid ,Medicare ,Infliximab ,Rituximab ,Pharmacist ,Voltaire Trial ,Bioequivalent ,Interchangeability ,Inflammatory Bowel Disease ,Crohns Disease ,Ulcerative Colitis ,Originator Biologic ,Colorectal Surgeon ,Rheumatology ,